Imunon, Inc. Accumulated Amortization, Debt Issuance Costs
Imunon, Inc. (IMNN) had Accumulated Amortization, Debt Issuance Costs of $282.92 thousand as of 2016-09-30, per its 10-Q filed 2016-11-10.
Discontinued › Notes › Debt
us-gaap:AccumulatedAmortizationDeferredFinanceCosts · last filed 2016-11-10
- 2016-09-30: Accumulated Amortization, Debt Issuance Costs $282.92K.
- 2015-12-31: Accumulated Amortization, Debt Issuance Costs $265.86K.
| Period end | Accumulated Amortization, Debt Issuance Costs |
|---|---|
| 2016-09-30 | $282.92K 10-Q · filed 2016-11-10 |
| 2015-12-31 | $265.86K 10-Q · filed 2016-11-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |